The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Brexit: at least one more year of pain?

Mon, 06th Jan 2020 10:31

* European stocks slide as U.S.-Iran tensions rise
* STOXX 600 down 1.2%, DAX -1.7%
* Airlines continue to slide on rising crude oil prices
* Risk-off: banks, chemicals, miners top fallers

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters and anchored today by Joice Alves. Reach her on Messenger to share your
thoughts on market moves: joice.alves.thomsonreuters.com@reuters.net

BREXIT: AT LEAST ONE MORE YEAR OF PAIN? (1030 GMT)
Yes, it's going to be one more (at least) year of Brexit madness as the UK and EU negotiate
trade terms of the divorce.
Though the chances of a full-fledged trade agreement by 2020 does look slim, ING says most
trade experts reckon it would theoretically be possible to agree a basic, tariff-free agreement
covering goods trade this year.
The bank gently reminds the EU-Canada deal, which took seven years from start to finish. ING
believes if the transition period is not extended by June, then the race to get the FTA done by
2020 is uncertain.
And a failure would mean an abrupt exit from the single market and customs union for British
firms. That's another reason why ING isn't expecting a big rise in UK investment this year.
Even if the deal is struck, ING warns that a "free-trade agreement (FTA) does not
mean frictionless trade" as it would mean plenty of costs and bureaucracy.
"To qualify for zero-tariffs, UK firms selling goods to Europe will likely have to prove
that their products are sufficiently British-made. For goods that have come through a complex
supply chain, documenting the origin of a product’s value is not always easy – and often it is
simpler and cheaper to pay the tariff than it is to try and document origin," ING explains.
"Whatever happens, one thing looks fairly clear: we aren’t going to know the answer to many
of these key questions until much later in 2020."
Uncertainty over the outcome of UK-EU trade negotiations is reflected in implied volatility
gauges in sterling (chart below) which are far more elevated than for other major currencies.



(Thyagaraju Adinarayan)
*****

OPENING SNAPSHOT: BOURSES EXTEND LOSSES (0900 GMT)
European bourses opened in negative territory this morning as investors chase safe-haven
assets after tensions between the U.S. and Iran exacerbated.
The pan-European index is down 1.3%, on track for its worst day in over a month
with cyclical sectors, banking and chemical, leading the losses.
Hikma Pharmaceuticals and Covestro shares are down more than 5%.
Britain's blue-chip index is down 0.8%. Morrison shares slide 3.7% after and
BofA downgrade and German rival Aldi reported strong sales in the UK.
Here is your snapshot of European bourses almost one hour from the open.
(Joice Alves)
*****

ON OUR RADAR: ATLANTIA AND RETAILERS (0757 GMT)
Futures point to a lower open in Europe this morning as investors are betting on safer
assets such as gold amid escalating Middle East tensions.
In Italy, shares of Atlantia are under pressure after the CEO of the company's unit
Autostrade told a local paper that the unit risks going bankrupt if Italy's government revokes
its motorway licence with limited compensation.
It is a public holiday in Milan but the stock exchange will be trading regular hours.
Christmas festivities gave a boost to the British arm of Aldi , with total sales
rising 7.9% in the four weeks to Dec. 24 year-on-year, driven by strong growth in beers, wines
and spirits as well as its premium ranges.
Good news also for German retailers as sales across the country was up 2.1% m/m and +2.8%
y/y in November, Germany statistics office said today.
In terms of macro news, UK, Spain, France, Germany and Italy are releasing PMI data this
morning.
On the M&A front, Covivio Hotels signed an agreement to acquire a portfolio of eight hotels
located in Rome, Florence, Venice, as well as in Nice, Prague and Budapest for €573 million
including capex..

Other corporate headlines this morning:
S.Korean restaurant owners voice concerns over $4 bln Delivery Hero deal
Ternienergia Signs Preliminary Contract With Buttol Srl For Sale Of Biodigestion &Biomethane
Production Plant

(Joice Alves)
*****



EPIPHANY CELEBRATIONS HIT BY MIDDLE EAST TENSIONS (0650 GMT)
European bourses are seen opening lower this morning as the escalating U.S.-Iran tensions
are prompting investors to bet on safe assets.
Gold surged close to a seven-year peak today, as investors flocked to the safe-haven metal,
while palladium surpassed the level of $2,000 to hit a record high.
Helsinki and Warsaw stock exchanges will be shut today for the Epiphany holiday. In Milan
and Madrid, the public holiday won't affect trading hours.
Financial spreadbetters at IG expect London's FTSE to open 42 points lower at 7,580,
Frankfurt's DAX to open 124 points lower at 13,095, and Paris' CAC to open 59 points lower at
5,985.

(Joice Alves)
*****



(Reporting by Danilo Masoni, Joice Alves, Julien Ponthus and Thyagaraju Adinarayan)

More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.